Int J Surg31 Aug 2024
The study established tumor fibrosis as an independent prognostic factor for survival in pancreatic ductal adenocarcinoma (PDAC) patients, identifying a 40% collagen fraction cut-off value crucial for prognosis differentiation. Utilizing a CT-based radiomics model, researchers achieved areas under the curve of 0.825 and 0.745 in…
Clin Mol Hepatol30 Aug 2024
A meta-analysis of 13 studies indicates that preoperative vibration-controlled transient elastography (vcte) is valuable for predicting postoperative complications and recurrence in hepatocellular carcinoma (HCC) patients. High vcte scores correlated with a significantly increased HCC recurrence rate (hazard ratio 2.14) and a notable risk of surgical…
J Surg Oncol28 Aug 2024
The study demonstrated that circulating tumor DNA (ctDNA) methylation analysis is a valuable prognostic tool for long-term outcomes in stage IV colorectal cancer. Patients with high levels of CHFR-rmv experienced significantly worse recurrence-free survival compared to those with low levels (p = 0.001), establishing CHFR-rmv…
Visc Med27 Aug 2024
An observational cohort study evaluated a standardized perioperative protocol for pancreatic oncological surgery from 2015 to 2022, finding significant reductions in postoperative complications. The rate of grade B and C pancreatic fistulas was 4.2%, while postoperative hemorrhage and delayed gastric emptying occurred in 2.5% and…
BMC Surg26 Aug 2024
A study involving 200 patients undergoing laparoscopic pancreatoduodenectomy demonstrated that 82.5% achieved a textbook outcome, indicating a smooth recovery without specified complications. Key independent risk factors included a higher likelihood for female patients and those with hard pancreatic texture. These findings suggest that specific patient…
World J Surg25 Aug 2024
Higher county-level provider density significantly correlates with lower hepatobiliary cancer incidence and mortality. Analysis across 1,359 counties revealed that areas with low provider density suffered higher rates of all-stage and late-stage cancer incidence, along with increased mortality rates. Notably, moderate and high provider density were…
J Hepatobiliary Pancreat Sci25 Aug 2024
A multicenter study revealed that conversion surgery following FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy significantly improves overall survival in patients with initially unresectable pancreatic cancer. The surgery group demonstrated a median overall survival of 34.4 months, compared to 19.8 months in the control group (hazard…
HPB & Spleen25 Aug 2024
CT-guided core needle biopsy (CNB) demonstrates high diagnostic yield and safety in pancreatic tumor evaluation. In a study of 43 biopsies across 42 patients, histological diagnosis was achieved in 93% of cases. CNB exhibited a sensitivity of 93%, specificity of 100%, and overall accuracy of…
Am J Gastroenterol24 Aug 2024
Findings indicate that older age at diagnosis of intraductal papillary mucinous neoplasms (IPMNs) correlates with a heightened long-term risk of pancreatic carcinoma. In a cohort of 3,142 IPMN patients, those aged 55-64, 65-74, and ≥75 exhibited adjusted subdistribution hazard ratios of 1.80, 2.56, and 3.31…
Surg Endosc23 Aug 2024
A consensus was reached among 23 surgeons regarding the safe implementation of minimally invasive hepato-pancreato-biliary (MIS HPB) surgery. Key outcomes included strong support for formal guidelines both at institutional and surgeon levels, with 91% advocating a minimum annual institutional volume cutoff for complex procedures. Additionally,…